Wells Fargo & Company »

Eikon Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $253k 19k 13.05

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
T. Rowe Price Associates
Vanguard Capital Management
EcoR1 Capital
Alliancebernstein
Geode Capital Management
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board

View all funds holding Eikon Therapeutics